| Price | 11.50p on 21-05-2026 at 18:35:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 12.00p |
| Sell | 11.00p |
| Last Trade: | Buy 17,207.00 at 11.60p |
| Day's Volume: | 172,357 |
| Last Close: | 11.50p |
| Open: | 11.50p |
| ISIN: | VGG042401262 |
| Day's Range | 11.25p - 11.50p |
| 52wk Range: | 8.25p - 24.00p |
| Market Capitalisation: | £5.95m |
| VWAP: | 11.31029p |
| Shares in Issue: | 51.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Crism Thera (CRTX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 17,207 | 11.60p | Ordinary |
15:12:12 - 21-May-26 |
| Buy* | 50,000 | 11.30p | Ordinary |
14:31:44 - 21-May-26 |
| Buy* | 50,000 | 11.29p | Ordinary |
14:31:27 - 21-May-26 |
| Buy* | 25,000 | 11.27p | Ordinary |
14:21:56 - 21-May-26 |
| Buy* | 20,000 | 11.30p | Ordinary |
11:50:30 - 21-May-26 |
| Sell* | 42 | 11.00p | Ordinary |
10:35:15 - 21-May-26 |
| Buy* | 43 | 11.50p | Ordinary |
09:27:59 - 21-May-26 |
| Buy* | 104 | 11.50p | SI Trade |
09:18:01 - 21-May-26 |
| Sell* | 9,128 | 11.00p | Ordinary |
09:17:29 - 21-May-26 |
| Unknown* | 0 | 11.00p | SI Trade |
08:37:07 - 21-May-26 |
Crism Thera (CRTX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Apr 2026 7:00 am | RNS | Positive Preclinical Data for Docetaxel ChemoSeed |
| 2nd Apr 2026 7:00 am | RNS | Board Changes |
| 25th Mar 2026 7:00 am | RNS | Phase 2 Clinical Trial Progress Update |
| 17th Mar 2026 7:00 am | RNS | Awarding of Orphan Drug Designation by the FDA |
| 17th Mar 2026 7:00 am | RNS | Awarding of Orphan Drug Designation by the FDA |
| 20th Jan 2026 7:00 am | RNS | Japanese Patent Grant |
| 9th Jan 2026 7:00 am | RNS | Results of Shareholder Analysis |
| 15th Dec 2025 2:29 pm | RNS | Result of Retail Offer |
| 10th Dec 2025 7:25 am | RNS | Retail Offer |
| 10th Dec 2025 7:00 am | RNS | Placing of £1,000,000 |
